Abstract
Background/Objectives:
The pathogenesis of enteritis after abdominal radiotherapy (RT) is unknown, although changes in fecal microbiota may be involved. Prebiotics stimulate the proliferation of Lactobacillus spp and Bifidobacterium spp, and this may have positive effects on the intestinal mucosa during abdominal RT.
Subjects/Methods:
We performed a randomized, double-blind, placebo-controlled trial involving patients with gynecological cancer who received abdominal RT after surgery. Patients were randomized to receive prebiotics or placebo. The prebiotic group received a mixture of fiber (50 inulin and 50% fructo-oligosaccharide), and the placebo group received 6 g of maltodextrin twice daily from 1 week before to 3 weeks after RT. The number of bowel movements and stool consistency was recorded daily. Diarrhea was evaluated according to the Common Toxicity Criteria of the National Cancer Institute. Stool consistency was assessed using the 7-point Bristol scale. Patients’ quality-of-life was evaluated at baseline and at completion of RT using the EORTC-QLQ-C30 (European Organization for Research and Treatment of Cancer quality-of-life Questionnaire C30) test.
Results:
Thirty-eight women with a mean age of 60.3±11.8 years participated in the study. Both groups (prebiotic (n=20) and placebo (n=18)) were comparable in their baseline characteristics. The number of bowel movements per month increased in both groups during RT. The number of bowel movements per day increased in both groups. The number of days with watery stool (Bristol score 7) was lower in the prebiotic group (3.3±4.4 to 2.2±1.6) than in the placebo group (P=0.08). With respect to quality-of-life, the symptoms with the highest score in the placebo group were insomnia at baseline and diarrhea toward the end of the treatment. In the prebiotic group, insomnia was the symptom with the highest score at both assessments, although the differences were not statistically significant.
Conclusions:
Prebiotics can improve the consistency of stools in gynecologic cancer patients on RT. This finding could have important implications in the quality-of-life of these patients during treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Walsh D . Deep tissue traumatism from roentgen ray exposure. Br Med J 1897; 2: 272–273.
Shadad AK, Sullivan FJ, Martin JD, Egan LJ . Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol 2013; 19: 199–208.
Andreyer HJ, Vlavianos P, Blake P, Dearnaley D, Norman AR, Tait D . Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist. Int J Radiat Oncol Biol Phys 2005; 62: 1464–1471.
Harb AH, Abou C, Sharara A . Radiation enteritis. Curr Gastroenterol Rep 2014; 16: 383–394.
Yarnold J, Brotons MC . Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol J Eur Soc Ther Radiol Oncol 2010; 97: 149–161.
Khalid U, Norman AR, Andreyev HJ . Elevated C-reactive protein levels are not a feature of uncomplicated radiation – induced bowel injury. Eur J Cancer Care 2007; 16: 346–350.
Hile A, Schmidt-Giese E, Hermann RM, Herrmann MK, Rave-Fränk M, Schirmer M et al. A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment. Scand J Gastroenterol 2008; 43: 52–58.
Lutgens L, Lambin O . Biomarkers for radiation-induced small bowel epithelial damage an emerging role for plasma Citruline. World J Gastroenterol 2007; 13: 3033–3042.
Sidhu R, Sanders DS, Morris AJ, McAlindon ME . Guidelines on study of small bowel endoscopy and capsule endoscopy in adults. Gut 2008; 57: 125–136.
Henson CC, Burden S, Davidson SE, Lal S . Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy (Review). Cochrane Database Syst Rev 2013; 11: CD009896.
Wedlake LJ, Shaw C, Whelan K, Andreyev HJ . Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther 2013; 37: 1046–1105.
Vidal-Casariego A, Calleja-Fernandez A, Ortiz Urbina-Gonzalez JJ, Cano-Rodríguez I, Cordido F, Ballesteros-Pomar MD . Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. J Parenter Enteral Nutr 2014; 38: 205–213.
Delia P, Sansotta G, Donato V, Messina G, Frosina P, Pergolizzi S et al. Prevention of radiation-induced diarrhea with the use of VSL#3 a new high-potency probiotic preparation. Am J Gastroenterol 2002; 97: 2150–2152.
Delia P, Sansotta G, Donato V, Frosina P, Messina G, De Renzis C et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 15: 912–915.
Urbancsek H, Kasar T, Mezen I, Neumann K . Results of a double-blind randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhea. Eur J Gastroenterol Hepatol 2001; 13: 391–396.
Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V . Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 2010; 5: 1–6.
Salminen E, Elomaa I, Minkkimen J, Vapaatalo H, Salminen S . Preservation of intestinal integrity during radiotherapy using live lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435–437.
Timko J . Probiotic as prevention of radiation-induced diarrhea. J Radiother Pract 1010; 9: 201–208.
Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P et al. Lactobacillus supplementation for diarrhea related to chemotherapy of colorectal cancer: a randomized study. Br J Cancer 2007; 97: 1028–1034.
Giralt J, Perez J, Verges R, Romero J, de la Fuente I, Biete A et al. Effects of probiotic Lactobacillus casei DN-114 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys 2008; 71: 1213–1219.
Gibson RJ, Keefe DM, Laila RV, Bateman E, Blijlevens N, Fijlstra M et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013; 21: 313–326.
Hamad A, Fragkos KC, Forbes A . A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr 2013; 32: 353–360.
Demers M, Dagnault A, Desjardins J . A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 2014; 33: 761–767.
Garcia –Peris P, Velasco C, Lozano MA, Moreno Y, Paron L, de la Cuerda C et al. Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial. Nutr Hosp 2012; 27: 1908–1915.
Douglas J . International commission on radiation units and measurements (Report 50). Med Phys 1994; 21: 833.
U.S. National Institutes of Health. Common Toxicity Criteria, version 20. National Institutes of Health, National Cancer, Institute: Bethesda, MD, USA, 1999. Available at ctep.cancer.gov (accessed 30 April 1999).
O’Donnell LJ, Virjee J, Heaton KW . Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990; 300: 439–440.
Fayers PM, Aaronson NK, Bjordal K EORTC QLQ-C30 scoring manual, 9th edn, EORTC: Brussels, Belgium, 1999..
Hovdenak N, Fajardo LF . Hauer – Jensen M. Acute radiation proctitis: A sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1111–1117.
Guarner F, Khan A, Garisch J, Eliakim R, Gangl A, Thomson A et al. World Gastroenterolgy Organization Global Guidelines. Probiotics and Prebiotics. J Clin Gastroenterol 2012; 46: 468–481.
Acknowledgements
We acknowledge the support of Vegenat SA for the performance of this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Garcia-Peris, P., Velasco, C., Hernandez, M. et al. Effect of inulin and fructo-oligosaccharide on the prevention of acute radiation enteritis in patients with gynecological cancer and impact on quality-of-life: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 70, 170–174 (2016). https://doi.org/10.1038/ejcn.2015.192
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.192
This article is cited by
-
The gut microbiota as a booster for radiotherapy: novel insights into radio-protection and radiation injury
Experimental Hematology & Oncology (2023)
-
High-yield production and purification of prebiotic inulin-type fructooligosaccharides
AMB Express (2022)
-
Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients
British Journal of Cancer (2022)
-
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
Supportive Care in Cancer (2019)